Instylla, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| (HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds (NCT05364502) | Instylla, Inc. | 2022-12-12 |
| Instylla HES Hypervascular Tumor Pivotal Study (NCT04523350) | Instylla, Inc. | 2021-03-05 |
Track Instylla, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.